AstraZeneca reported tie-up talks with Bristol-Myers Squibb are moving stocks. Analysts are puzzled.
AstraZeneca shares were slumping while Bristol-Myers Squibb was jumping on Monday on reported deal talks. But the big question is why these two pharmaceutical giants would want to come together in the first place.
AstraZeneca shares were slumping while Bristol-Myers Squibb was jumping on Monday on reported deal talks. But the big question is why these two pharmaceutical giants would want to come together in the first place. This story matters for Finance & Markets readers tracking lending. Reported by marketwatch.com. Read the full original at the source link below.
Originally reported by marketwatch.com. LendingNews curates and briefs the finance & markets stories that matter. Our editorial policy →